(S,S)-DTB-Bn-SIPHOX

Modify Date: 2024-01-23 23:35:52

(S,S)-DTB-Bn-SIPHOX Structure
(S,S)-DTB-Bn-SIPHOX structure
Common Name (S,S)-DTB-Bn-SIPHOX
CAS Number 1040274-10-9 Molecular Weight 788.09200
Density N/A Boiling Point 788.7±60.0 °C
Molecular Formula C55H66NOP Melting Point 159-161 °C
MSDS N/A Flash Point N/A

 Names

Name [(3S)-4'-[(4S)-4-benzyl-4,5-dihydro-1,3-oxazol-2-yl]-3,3'-spirobi[1,2-dihydroindene]-4-yl]-bis(3,5-ditert-butylphenyl)phosphane
Synonym More Synonyms

 Chemical & Physical Properties

Boiling Point 788.7±60.0 °C
Melting Point 159-161 °C
Molecular Formula C55H66NOP
Molecular Weight 788.09200
Exact Mass 787.48800
PSA 35.18000
LogP 11.63700
Storage condition 2-8°C

 MSDS


Section 1: Product Identification
(S)-(-)-7’-[4(S)-(Benzyl)oxazol-2-yl]-7-di(3,5-di-t-butylphenyl)phosphino-2,2’,3,3’-tetrahydro-1,1’-spirobiindane,
Chemical Name:
min. 97% (Sa,S)-DTB-Bn-SIPHOX
CAS Registry Number:1040274-10-9
Formula:C55H66NOP
EINECS Number:none
Chemical Family:organophosphine ligand
Synonym:(Sa,S)-DTB-Bn-SIPHOX

Section 2: Composition and Information on Ingredients
IngredientCAS NumberPercentACGIH (TWA)OSHA (PEL)
Title compound1040274-10-9100%no datano data

Section 3: Hazards Identification
Emergency Overview:Irritating to skin, eyes and respiratory tract.
Primary Routes of Exposure:Ingestion, inhalation, eyes
Eye Contact:Causes slight to mild irritation of the eyes.
Skin Contact:Causes slight to mild irritation of the skin.
Inhalation:Irritating to the nose, mucous membranes and respiratory tract.
Ingestion:No information available on the physiological effects of ingestion. May be harmful if swallowed.
Acute Health Affects:Irritating to skin, eyes and respiratory tract.
Chronic Health Affects:No information on long-term chronic effects.
NTP:No
IARC:No
OSHA:No

SECTION 4: First Aid Measures
Immediately flush the eyes with copious amounts of water for at least 10-15 minutes. A victim may need
Eye Exposure:
assistance in keeping their eye lids open. Get immediate medical attention.
Wash the affected area with water. Remove contaminated clothes if necessary. Seek medical assistance if
Skin Exposure:
irritation persists.
Remove the victim to fresh air. Closely monitor the victim for signs of respiratory problems, such as difficulty
Inhalation:
in breathing, coughing, wheezing, or pain. In such cases seek immediate medical assistance.
Seek medical attention immediately. Keep the victim calm. Give the victim water (only if conscious). Induce
Ingestion:
vomiting only if directed by medical personnel.

SECTION 5: Fire Fighting Measures
Flash Point:no data
Autoignition Temperature:no data
Explosion Limits:no data
Extinguishing Medium:carbon dioxide, dry powder or foam
If this product is involved in a fire, fire fighters should be equipped with a NIOSH approved positive pressure
Special Fire Fighting Procedures:
self-contained breathing apparatus and full protective clothing.
Hazardous Combustion andIf involved in a fire this material may emit irritating fumes.
Decomposion Products:
Unusual Fire or Explosion Hazards: No unusual fire or explosion hazards.

SECTION 6: Accidental Release Measures
Spill and Leak Procedures:Small spills can be mixed with vermiculite or sodium carbonate and swept up.

SECTION 7: Handling and Storage
Store in a tightly sealed container under an inert atmosphere of nitrogen or argon. Keep in a cool, dry,
Handling and Storage:
well-ventilated place.

SECTION 8: Exposure Controls and Personal Protection
Eye Protection:Always wear approved safety glasses when handling a chemical substance in the laboratory.
Skin Protection:Wear protective clothing and gloves.
Ventilation:Handle the material in an efficient fume hood.
If ventilation is not available a respirator should be worn. The use of respirators requires a Respirator
Respirator:
Protection Program to be in compliance with 29 CFR 1910.134.
Ventilation:Handle the material in an efficient fume hood.
Additional Protection:No additional protection required.

SECTION 9: Physical and Chemical Properties
Color and Form:white solid
Molecular Weight:788.09
Melting Point:159-161°
Boiling Point:no data
Vapor Pressure:no data
Specific Gravity:no data
Odor:none
Solubility in Water:insoluble

SECTION 10: Stability and Reactivity
Stability:moisture sensitive
Hazardous Polymerization:no hazardous polymerization
Conditions to Avoid:prolonged exposure to moisture
Incompatibility:strong oxidizing agents
Decomposition Products:carbon monoxide, carbon dioxide, phosphorus oxides and organic fumes.

SECTION 11: Toxicological Information
RTECS Data:No information available in the RTECS files.
Carcinogenic Effects:no data
Mutagenic Effects:no data
Tetratogenic Effects:no data

SECTION 12: Ecological Information
Ecological Information:No information available

SECTION 13: Disposal Considerations
Disposal:Dispose of according to local, state and federal regulations.

SECTION 14: Transportation
Shipping Name (CFR):Non-hazardous
Hazard Class (CFR):NA
Additional Hazard Class (CFR):NA
Packaging Group (CFR):NA
UN ID Number (CFR):NA
Shipping Name (IATA):Non-hazardous
Hazard Class (IATA):NA
Additional Hazard Class (IATA):NA
Packaging Group (IATA):NA
UN ID Number (IATA):NA

SECTION 15: Regulatory Information
TSCA:Not listed in the TSCA inventory
SARA (Title 313):Not regulated under SARA 313
Second Ingredient:none


SECTION 16 - ADDITIONAL INFORMATION
N/A

 Synonyms

(S,S)-7-[4-(Benzyl)oxazol-2-yl]-7 inverted exclamation marka-di(3,5-ditertbutylphenyl)phosphinyl-1,1 inverted exclamation marka-spirobiindane
Top Suppliers:I want be here


Get all suppliers and price by the below link:

(S,S)-DTB-Bn-SIPHOX suppliers

(S,S)-DTB-Bn-SIPHOX price

Related Compounds: More...
[((Sa,S)-dtb-bn-siphox)ir(cod)]barf
1192772-64-7
[2-[(1S)-7'-[BIS[3,5-BIS(TERT-BUTYL)PHENYL]PHOSPHINO-ΚP]-2,2',3,3'-TETRAHYDRO-1,1'-SPIROBI[1H-INDEN]-7-YL]Chemicalbook-4,5-DIHYDROOXAZOLE-ΚN3][(1,2,5,6-Η)-1,5-CYCLOOCTADIENE]-(+)IRIDIUM(I)TETRAKIS[3,5-BIS(TRIFLUOROMETHYL)PHE
1192772-21-6
(S)-DTB-SIPHOX
1040274-18-7
(Sa,S)-Ph-Bn-SIPHOX
913829-88-6
(Sa,S)-Xyl-Bn-SIPHOX
913829-90-0
2-Pyridinemethanamine,N-[(1S)-7'-[bis[3,5-bis(1,1-dimethylethyl)phenyl]phosphino]-2,2',3,3'-tetrahydro-1,1'-spirobi[1H-inden]-7-yl]-3-methyl-
2177259-16-2
(S)-DTB-SpiroSAP
2177266-21-4
S,S-N,N,N',N',2,2-hexamethyl-1,3-Dioxolane-4,5-dicarboxamide
111828-49-0
S,S-dimethyl-N-(2-pyridyl)sulfilimine
42860-85-5
(4-(2-Fluorophenyl)piperazin-1-yl)(1-(6-phenylpyridazin-3-yl)piperidin-4-yl)methanone
1105230-36-1
N-(3,4-dimethoxyphenethyl)-1-(6-phenylpyridazin-3-yl)piperidine-4-carboxamide
1105216-90-7
N-(1,3-benzodioxol-5-ylmethyl)-1-(6-phenylpyridazin-3-yl)piperidine-4-carboxamide
1105230-44-1
1-(6-phenylpyridazin-3-yl)-N-(pyridin-3-ylmethyl)piperidine-4-carboxamide
1105216-95-2
1-(6-phenylpyridazin-3-yl)-N-(pyridin-2-ylmethyl)piperidine-4-carboxamide
1105230-51-0
Methyl 4-(1-(6-phenylpyridazin-3-yl)piperidine-4-carboxamido)benzoate
1105217-00-2
1-(6-phenylpyridazin-3-yl)-N-(pyridin-3-yl)piperidine-4-carboxamide
1105217-05-7
4-cyclopentyl-4H-thieno[3,2-b]pyrrole-5-carboxylic acid
1146291-78-2
1-(6-phenylpyridazin-3-yl)-N-(pyridin-4-ylmethyl)piperidine-4-carboxamide
1105217-10-4
4-(2-Methoxy-5-bromo-phenyl)-pyrimidin-2-ylamine
915070-51-8